- Home
- DSGN vs WHF Comparison
DSGN vs WHF Comparison
Compare DSGN & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- WHF
- Stock Information
- Founded
- DSGN 2017
- WHF 2011
- Country
- DSGN United States
- WHF United States
- Employees
- DSGN N/A
- WHF N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- WHF Finance Companies
- Sector
- DSGN Health Care
- WHF Finance
- Exchange
- DSGN Nasdaq
- WHF Nasdaq
- Market Cap
- DSGN 224.8M
- WHF 212.0M
- IPO Year
- DSGN 2021
- WHF 2012
- Fundamental
- Price
- DSGN $3.71
- WHF $8.73
- Analyst Decision
- DSGN Hold
- WHF Sell
- Analyst Count
- DSGN 1
- WHF 4
- Target Price
- DSGN $4.00
- WHF $10.83
- AVG Volume (30 Days)
- DSGN 93.8K
- WHF 97.1K
- Earning Date
- DSGN 08-04-2025
- WHF 08-07-2025
- Dividend Yield
- DSGN N/A
- WHF 17.72%
- EPS Growth
- DSGN N/A
- WHF N/A
- EPS
- DSGN N/A
- WHF 0.39
- Revenue
- DSGN N/A
- WHF $86,143,000.00
- Revenue This Year
- DSGN N/A
- WHF N/A
- Revenue Next Year
- DSGN N/A
- WHF N/A
- P/E Ratio
- DSGN N/A
- WHF $22.08
- Revenue Growth
- DSGN N/A
- WHF N/A
- 52 Week Low
- DSGN $2.60
- WHF $8.44
- 52 Week High
- DSGN $7.77
- WHF $12.73
- Technical
- Relative Strength Index (RSI)
- DSGN 47.78
- WHF 38.47
- Support Level
- DSGN $3.66
- WHF $9.18
- Resistance Level
- DSGN $3.84
- WHF $9.66
- Average True Range (ATR)
- DSGN 0.25
- WHF 0.16
- MACD
- DSGN -0.02
- WHF -0.00
- Stochastic Oscillator
- DSGN 18.06
- WHF 0.00
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.